Back to event listing

MAT Waiver Training

1:00pm - December 14, 2020 | Timezone: US/Pacific
Pacific Southwest ATTC
Registration Deadline: December 7, 2020
Need more information?
Contact us at sbertea@mednet.ucla.edu

Monday and Wednesday, 
December 14 and 16 
1 pm - 5 pm each day
Instructors:   
Monica Faria, MD & Michael Dekker, DO Arizona Society of Addiction Medicine
Location:  
Online VIA Zoom Meetings
CMEs: 8 hours (free!)
No Cost to Attend
Registration link: 

https://na.eventscloud.com/ehome/index.php?eventid=580735& 

Description:

To prescribe buprenorphine, one of three medications approved by the FDA for the 
treatment of opioid use disorder, physicians are required to complete 8 hours of training in order to apply to the 
Drug Enforcement Agency for a waiver. 

This course will provide prescribers with the full 8 hours of required MAT training. 


Nurse Practitioners (NP), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), Certified Nurse Midwives (CNM) and Physician Assistants (PA) are required to complete 24 hours of training including the 8 hour MAT training.

At the conclusion of this activity participants should be able to:

·    Screen and identify patients with OUD and define evidence-based treatments.
·    Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
·    Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
·    Explain the process of buprenorphine induction as well as stabilization and maintenance.
·    Discuss all FDA approved antagonist and agonist medications to treat OUD.
·    Discuss basic office protocols including medical record documentation and confidentially.
·    Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
·    Recognize the importance of obtaining a waiver to begin treating patients with OUD.